Sumitomo Dainippon Pharma Co Ltd - Ebitda

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Ebitda" stands at 145.41 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2022.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 86.15 Billion JPY for the item "Ebitda" represents an increase of 228.96 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 86.15 Billion JPY for the item "Ebitda" represents an increase of 543.63 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 145.41 Billion JPY for the item "Ebitda" represents an increase of 264.95 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 367.22 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 367.22 Billion Japanese Yens.
The 3 year change is 44.78 Billion Japanese Yens.
The 5 year change is 62.19 Billion Japanese Yens.
The 10 year change is 110.90 Billion Japanese Yens.

The Serie's long term average value is 50.28 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 95.14 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +409.75 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 06/30/2022, to it's latest available value, on 09/30/2025, is -20.77 Billion.